Search research articles
Contact Us
Filters
Showing results (291-300 of 302) with videos related to
Page
of 31
Sort By:
Gene
|
October 15, 2014
MicroRNA-146a reduces IL-1 dependent inflammatory responses in the intervertebral disc
Su-Xi Gu, Xin Li, John L Hamilton, et al.
Science China. Life Sciences
|
July 17, 2023
FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway
Guanglei Chen, Lisha Sun, Xi Gu, et al.
Science China. Life Sciences
|
June 23, 2025
Erratum to: FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway
Guanglei Chen, Lisha Sun, Xi Gu, et al.
Science (New York, N.Y.)
|
December 23, 2021
Pol IV and RDR2: A two-RNA-polymerase machine that produces double-stranded RNA
Kun Huang, Xiao-Xian Wu, Cheng-Li Fang, et al.
Reviews in Cardiovascular Medicine
|
March 3, 2025
Incorporating Circulating Plasma Interleukin-10 Enhanced Risk Predictability of Mortality in Acute Type A Aortic Dissection Surgery
Yi-Fei Diao, Zhi-Bin Chen, Jia-Xi Gu, et al.
The Journal of Clinical Investigation
|
July 15, 2010
Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells
Jiang-Hong Man, Bing Liang, Yue-Xi Gu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 26, 2021
Gene editing in a Myo6 semi-dominant mouse model rescues auditory function
Yuanyuan Xue, Xinde Hu, Daqi Wang, et al.
Elife
|
December 22, 2023
Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot study
Guanglei Chen, Xi Gu, Jinqi Xue, et al.
The Lancet Regional Health. Western Pacific
|
October 13, 2025
Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trial
Jinqi Xue, Huilian Shan, Fang Qiu, et al.
Nature Communications
|
July 2, 2025
Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial
Nan Niu, Jinqi Xue, Guanglei Chen, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 302) with videos related to
Sort By:
Page
of 31
Gene
|
October 15, 2014
MicroRNA-146a reduces IL-1 dependent inflammatory responses in the intervertebral disc
Su-Xi Gu, Xin Li, John L Hamilton, et al.
Science China. Life Sciences
|
July 17, 2023
FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway
Guanglei Chen, Lisha Sun, Xi Gu, et al.
Science China. Life Sciences
|
June 23, 2025
Erratum to: FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway
Guanglei Chen, Lisha Sun, Xi Gu, et al.
Science (New York, N.Y.)
|
December 23, 2021
Pol IV and RDR2: A two-RNA-polymerase machine that produces double-stranded RNA
Kun Huang, Xiao-Xian Wu, Cheng-Li Fang, et al.
Reviews in Cardiovascular Medicine
|
March 3, 2025
Incorporating Circulating Plasma Interleukin-10 Enhanced Risk Predictability of Mortality in Acute Type A Aortic Dissection Surgery
Yi-Fei Diao, Zhi-Bin Chen, Jia-Xi Gu, et al.
The Journal of Clinical Investigation
|
July 15, 2010
Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells
Jiang-Hong Man, Bing Liang, Yue-Xi Gu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 26, 2021
Gene editing in a Myo6 semi-dominant mouse model rescues auditory function
Yuanyuan Xue, Xinde Hu, Daqi Wang, et al.
Elife
|
December 22, 2023
Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot study
Guanglei Chen, Xi Gu, Jinqi Xue, et al.
The Lancet Regional Health. Western Pacific
|
October 13, 2025
Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trial
Jinqi Xue, Huilian Shan, Fang Qiu, et al.
Nature Communications
|
July 2, 2025
Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial
Nan Niu, Jinqi Xue, Guanglei Chen, et al.
Page
of 31